Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Israeli Oramed to raise $50 million from two Chinese investors

Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50 million Investment and Licensing Deal in China

oramed

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP),  has signed a non-binding Letter of Intent (LoI) for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science & Technology Park Investments and Development Co., Ltd. potentially valued at $50 million plus royalty payments.

Oramed, a clinical-stage pharmaceutical company focused on the development of oral insulin capsule delivery systems,  will receive $500, 000 in exchange for exclusively negotiating with Sinopharm-Hefei for 60 days, while the final terms of the agreement are negotiated and finalized.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

The transaction which additionally includes 10% royalties on sales, will allow Sinopharm-Hefei to purchase a roughly 10% stake in Oramed Pharmaceuticals and acquire rights for oral insulin in China.

The terms are to be broken down as follows: Oramed will sell Sinopharm-Hefei 1, 155, 367 shares of common stock for approximately $12 million.

In addition, Oramed’s wholly owned subsidiary, Oramed Ltd, will license to Sinopharm-Hefei the exclusive rights to ORMD-0801, oral insulin capsule in China, for a total amount of $38 million of which $18 million will be paid upon the signing of the license agreement and the remaining $20 million will be paid following the completion, and release of results, of Oramed’s current Phase IIb trial in the United States.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.